“…In recent years, scientists have investigated and created many novel types of ophthalmic formulations, including micelles, liposomes, nanoparticles, nanosuspensions, dendritic polymers, microneedles, cubosomes, niosomes, nanowafers, etc., providing a number of alternatives to the drug delivery of traditional ophthalmic formulations [ 13 ]. Nanogels are formed from natural polymers, synthetic polymers, or a combination thereof, and their three-dimensional network structure allows for the encapsulation of small molecules, oligonucleotides, and even proteins [ 14 ], whose unique characteristics make it possible for drug delivery, diagnostics, and imaging and have great potential for application in the biomedical, tissue engineering, and pharmaceutical fields [ 15 , 16 , 17 , 18 , 19 ]. Recently, the application of nanogels in the eye has attracted more attention, not only as an upgrade to hydrogels or microgels [ 20 ] but also as a nanocarrier that can be combined with micelles, liposomes, dendritic polymers, etc., which are superior alternatives since they have higher biocompatibility, drug loading capacity, and lower toxicity [ 21 , 22 , 23 ].…”